ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
会议论文

Final progression-free survival, interim overall survival, and biomarker analyses of CHOICE-01: A phase 3 study of toripalimab versus placebo in combination with first-line chemotherapy for advanced NSCLC without EGFR/ALK mutations.

Wang, Jie; Wang, Zhijie; Wu, Lin; Li, Baolan; Cheng, Ying; Li, Xiaoling; Wang, Xicheng; Han, Liang; Wu, Xiaohong; Fan, Yun; Yu, Yan; Lv, Dongqing; Shi, Jianhua; Huang, Jianjin; Zhou, Shaozhang; Han, Baohui; Sun, Guogui; Guo, Qisen; Ji, Youxin; Zhu, Xiaoli广东药学院; 江南大学; 哈尔滨医科大学; 中国医学科学院; 中国医学科学院北京协和医院; 1
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)2022-6-1
11阅读
引用收藏
分享
相关
加载中…
  • Final overall survival and biomarker analyses of CHOICE-01: A double-blind randomized phase 3 study of toripalimab versus placebo in combination chemotherapy for advanced NSCLC without EGFR/ALK mutations
    Wang, Jie; Wang, Zhijie; Wu, Lin; Li, Baolan; Cheng, Ying; Li, Xiaoling; Wang, Xicheng; Han, Liang; Wu, Xiaohong; Fan, Yun; Yu, Yan; Lv, Dongqing; Shi, Jianhua; Huang, Jianjin; Zhou, Shaozhang; Han, Baohui; Sun, Guogui; Guo, Qisen; Ji, Youxin; Zhu, XiaoliAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2023-06-02 To 2023-06-06.
  • Uliledlimab and toripalimab combination therapy in treatment naive advanced NSCLC: Phase 1b/2 clinical trial results using CD73 as a potential predictive biomarker
    Zhou, Qing; Wu, Lin; Jiang, Bo; Du, Yingying; Wang, Buhai; Hu, Xiaohua; He, Yong; Zhao, Mingfang; Yao, Yu; Cui, Jiuwei; Dong, Xiaorong; Zhang, Haibo; Ma, Rui; Wang, Huijuan; Zhang, Jian; Xia, Jinjing; Zhang, Yanni; Hayslip, John W.; Zhu, Andrew X.; Wu, Yi-LongAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2023-06-02 To 2023-06-06.
  • Perioperative toripalimab plus platinum-doublet chemotherapy vs chemotherapy in resectable stage II/III non-small cell lung cancer (NSCLC): Interim event-free survival (EFS) analysis of the phase III Neotorch study.
    Lu, Shun; Wu, Lin; Zhang, Wei; Zhang, Peng; Wang, Wenxiang; Fang, Wentao; Xing, Wenqun; Chen, Qixun; Mei, Jiandong; Yang, Lin; Tan, Lijie; Sun, Xiaohong; Xu, Shidong; Hu, Xiaohua; Yu, Guohua; Yu, Dongliang; Shan, Jinlu; Yang, Nong; Chen, Yuping; Tian, HuiAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 2023-11 To 2023-11.被引 29
查看全部 →

会议信息

会议名称
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
会议日期
2022-06-03 至 2022-06-07
论文集名
JOURNAL OF CLINICAL ONCOLOGY
发表日期
2022-06-01
资助标注
Shanghai Junshi Biosciences
收录
ISTP · SCIE

作者

  • W

    Wang, Jie (第一作者)

  • W

    Wang, Zhijie

查看全部 20 位作者收起作者
  • W

    Wu, Lin

  • L

    Li, Baolan

  • C

    Cheng, Ying

  • L

    Li, Xiaoling

  • W

    Wang, Xicheng

  • H

    Han, Liang

  • W

    Wu, Xiaohong

  • F

    Fan, Yun

  • Y

    Yu, Yan

  • L

    Lv, Dongqing

  • S

    Shi, Jianhua

  • H

    Huang, Jianjin

  • Z

    Zhou, Shaozhang

  • H

    Han, Baohui

  • S

    Sun, Guogui

  • G

    Guo, Qisen

  • J

    Ji, Youxin

  • Z

    Zhu, Xiaoli

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417